Trade BCRX anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
BioCryst Pharmaceuticals, Inc. (BCRX) is trading at US$9.74, down 1.37% today as of Aug 28, 12:48 EDT. The company has a market capitalisation of US$2.44B. Over the past 52 weeks, BCRX has traded between US$6.00 and US$11.22. On Syfe you can trade BCRX with $0 commission and add it to your watchlist.
| Previous close | US$9.87 |
|---|---|
| Market cap | US$2.44B |
| 52-week range | US$6.00 – US$11.22 |
| Volume | 2.41M |
| Exchange | US |
Add to Watchlist
Set Price Alert
BioCryst Pharmaceuticals, Inc.
BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.
Year: 1994
BioCryst Pharmaceuticals, Inc. (BCRX) stock is trading at US$9.74, -1.37% from the previous close of US$9.87.
The market cap for BioCryst Pharmaceuticals, Inc. (BCRX) stock is approximately US$2.44B.
The 52-week high for BioCryst Pharmaceuticals, Inc. (BCRX) stock is US$11.22.
The 52-week low for BioCryst Pharmaceuticals, Inc. (BCRX) stock is US$6.00.
BioCryst Pharmaceuticals, Inc. (BCRX) does not currently pay a dividend.
Stay on top of BCRX
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
